Pulmonary blood pressure, not flow, is associated with net endothelin-1 production in the lungs of patients with congenital heart disease and normal pulmonary vascular resistance

Journal of Thoracic and Cardiovascular Surgery

Volumn 126, Issue 6, 2003, Pages 1724-1729

  Fratz, Sohrab ^a   Geiger, Ralf ^b   Kresse, Hans ^a   Roemer, Gabriele ^a   Hennig, Michael ^c   Sebening, Walter ^a   Hess, John ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN 1;

ADOLESCENT; ADULT; ARTICLE; CARDIOPULMONARY HEMODYNAMICS; CHILD; CONGENITAL HEART DISEASE; FEMALE; HUMAN; LUNG ARTERY PRESSURE; LUNG BLOOD FLOW; LUNG VASCULAR RESISTANCE; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION;

EID: 0346434103     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5223(03)00937-1     Document Type: Article

References (24)

1. Hoffman JI, Rudolph AM, Heymann MA. Pulmonary vascular disease with congenital heart lesions: pathologic features and causes. Circulation. 1981;64:873-7.
2. Heath D, Edwards J. The pathology of hypertensive pulmonary vascular disease. Circulation. 1958;18:533-47.
3. Rabinovitch M, Haworth SG, Castaneda AR, Nadas AS, Reid LM. Lung biopsy in congenital heart disease: a morphometric approach to pulmonary vascular disease. Circulation. 1978;58:1107-22.
4. Wagenvoort CA. Lung biopsy specimens in the evaluation of pulmonary vascular disease. Chest. 1980;77:614-25.
5. Stewart DJ, Levy RD, Cernacek P, Langleben D. Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease? Ann Intern Med. 1991;114:464-9.
6. Yoshibayashi M, Nishioka K, Nakao K, Saito Y, Matsumura M, Ueda T, et al. Plasma endothelin concentrations in patients with pulmonary hypertension associated with congenital heart defects. Evidence for increased production of endothelin in pulmonary circulation. Circulation. 1991;84:2280-5.
7. Giaid A, Yanagisawa M, Langleben D, Michel RP, Levy R, Shennib H, et al. Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. N Engl J Med. 1993;328:1732-9.
8. Dupuis J, Cernacek P, Tardif JC, Stewart DJ, Gosselin G, Dyrda I, et al. Reduced pulmonary clearance of endothelin-1 in pulmonary hypertension. Am Heart J. 1998;135:614-20.
9. Cacoub P, Dorent R, Maistre G, Nataf P, Carayon A, Piette C, et al. Endothelin-1 in primary pulmonary hypertension and the Eisenmenger syndrome. Am J Cardiol. 1993;71:448-50.
10. Anonymous. Bosentan (Tracleer) for pulmonary arterial hypertension. Med Lett Drugs Ther. 2002;44:30-2.
11. Vincent JA, Ross RD, Kassab J, Hsu JM, Pinsky WW. Relation of elevated plasma endothelin in congenital heart disease to increased pulmonary blood flow. Am J Cardiol. 1993;71:1204-7.
12. Adatia I, Haworth SG. Circulating endothelin in children with congenital heart disease. Br Heart J. 1993;69:233-6.
13. Ishikawa S, Miyauchi T, Ueno H, Ushinohama H, Sagawa K, Fusazaki N, et al. Influence of pulmonary blood pressure and flow on endothelin-1 production in humans. J Cardiovasc Pharmacol. 1995;26(Suppl 3):S429-33.
14. Gorenflo M, Gross P, Bodey A, Schmitz L, Brockmeier K, Berger F, Bein G, Lange PE. Plasma endothelin-1 in patients with left-to-right shunt. Am Heart J. 1995;130:537-42.
15. Ikemoto Y, Teraguchi M, Takaya J, Nogi S, Kobayashi Y. Plasma levels of nitric oxide products and endothelin in pulmonary hypertension with congenital heart disease. Acta Paediatr. 1998;87:715-6.
16. Tutar HE, Imamoglu A, Atalay S, Gumus H, Akar N. Plasma endothelin-1 levels in patients with left-to-right shunt with or without pulmonary hypertension. Int J Cardiol. 1999;70:57-62.
17. Black S, Fineman J, Johengen M, Bristow J, Soifer S. Increased pulmonary blood flow alters the molecular regulation of vascular reactivity in the lamb. Chest. 1998;114(1 Suppl):39S.
18. Ross RD. Endothelin and pulmonary blood flow. Am Heart J. 1996;132:1317-9.
19. Dschietzig T, Richter C, Bartsch C, Bohme C, Heinze D, Ott F, et al. Flow-induced pressure differentially regulates endothelin-1, urotensin II, adrenomedullin, and relaxin in pulmonary vascular endothelium. Biochem Biophys Res Commun. 2001;289:245-51.
20. Lister G, Hoffman JI, Rudolph AM. Oxygen uptake in infants and children: a simple method for measurement. Pediatrics. 1974;53:656-62.
21. LaFarge CG, Miettinen OS. The estimation of oxygen consumption. Cardiovasc Res. 1970;4:23-30.
22. Yoshibayashi M, Nishioka K, Nakao K, Saito Y, Temma S, Matsumura M, et al. Plasma endothelin levels in healthy children: high values in early infancy. J Cardiovasc Pharmacol. 1991;17(Suppl 7): S404-5.
23. de Nucci G, Thomas R, D'Orleans Juste P, Antunes E, Walder C, Warner TD, et al. Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc Natl Acad Sci U S A. 1988;85:9797-800.
24. Black SM, Bekker JM, Johengen MJ, Parry AJ, Soifer SJ, Fineman JR. Altered regulation of the ET-1 cascade in lambs with increased pulmonary blood flow and pulmonary hypertension. Pediatr Res. 2000;47:97-106.